PLATelet inhibition and patient Outcomes(English)

• international, randomized, double-blind, event-driven trial involving patients hospitalized for ST-elevation ACS with scheduled primary PCI or for non–ST-elevation ACS, with PLATO-defined major bleeding as primary safety variable
• ACS, PCI, ST
• Thrombocyte /thrombosis, Quality and outcomes, Clinical trials
• https://doi.org…ahj.2009.01.003